News & Events
Spinifex Pharmaceuticals Appoints Neuroscience Expert Dr Ronald Marcus as Chief Medical Officer
03 / 06 / 2014
Celladon Corporation Appoints Paul Cleveland as President and Chief Financial Officer
03 / 06 / 2014
Spinifex Pharmaceuticals Strengthens Scientific Advisory Board (SAB) with Experts in Chronic Pain
27 / 05 / 2014
Sunshine Heart Announces Presentations at the Annual Meeting of the Heart Failure Association
14 / 05 / 2014
PLC Systems Proposes Series of Business Transactions Designed to Preserve Value for Shareholders
14 / 05 / 2014
FDA Approves Teva SYNRIBO® (Omacetaxine Mepesuccinate) for Injection for Home Administration
07 / 05 / 2014
New Labeling will Offer People Living with Chronic Myeloid Leukemia (CML) More Treatment Flexibility
Celladon Receives Breakthrough Therapy Designation From FDA for MYDICAR(R)
10 / 04 / 2014
MYDICAR is First Gene Therapy Reported to Receive Breakthrough Designation From FDA's Center for Biologics Evaluation and Research (CBER)
Sunshine Heart Announces Presentations at 2014 International Society for Heart and Lung
03 / 04 / 2014
Spinifex PhII Results Show EMA401 to be Effective in Reducing Pain in Postherpetic Neuralgia
20 / 03 / 2014
Hearing Specialists offer Treatments for Ringing
05 / 03 / 2014
Hearing specialists offer hope to patients suffering from tinnitus, which causes ringing in the ears.
Celladon Corporation Announces Appointments of Dr. Peter Honig and Dr. Patrick Yang to Its Board
03 / 03 / 2014
Celladon Announces Exercise in Full and Closing of Underwriters' Option to Purchase Additional Shares
27 / 02 / 2014
Teva Announces Full FDA Approval of SYNRIBO® (Omacetaxine Mepesuccinate) for Injection
17 / 02 / 2014
Celladon features in Circulation Research: Lasting Effects of AAV1/SERCA2a in Heart Failure
13 / 01 / 2014
Displaying records 26-50 of 53